Losing Control of Controlled Substances? The Case of Telehealth Prescriptions
In May 2022, the Department of Justice began investigating Cerebral for “possible violations” of the Controlled Substances Act.

In May 2022, the Department of Justice began investigating Cerebral for “possible violations” of the Controlled Substances Act.
Most doctors want a federal medical license. But would the Constitution allow Congress to control accreditation?
This policy doesn’t seem to encourage frequent and convenient testing now, which is particularly important as we face the current delta surge.
Which of the telehealth regulatory waivers enacted during the pandemic should become permanent?
New reimbursement codes for virtual patient monitoring may soon be incorporated into Medicare’s fee schedule.
Reforms to Medicare’s traditional coverage and reimbursement approaches that harness the digital revolution can help the program secure additional value.
Policy and regulation will play a significant role in determining whether these health care modalities are here to stay.
At-home COVID-19 testing illustrates how even the most well-financed efforts can miss opportunities to ensure equity and expand access.